Richard S. Bedlack, MD, PhD, MS

Related Content

Services

• Neurological Disorders

Director, Duke MDA/ALS Clinic

Department / Division:
Medicine / Neurology

Address:
DUMC 3333
Durham, NC 27710

Appointment Telephone:
919-668-7600

Office Telephone:
919-668-2839

Fax Telephone:
919-668-2901

• MD, PhD, University of Connecticut School of Medicine, 1995

• Neurology, Duke University Medical Center, 1996-1999
• Neuromuscular Disease, Duke University Medical Center, 1999-2000

• MS, Clinical Research, Duke University Medical Center, 2004

Clinical Interests:
Interested in all neuromuscular diseases especially ALS, motorneuron disease, SMA, CMT, CIDP, diabetic neuropathy, myasthenia gravis, LEMS

Research Interests:
1. Investigator-initiated and multi-center clinical trials testing new treatments for amyotrophic lateral sclerosis and diabetic neuropathy.

2. Epidemiologic studies to better understand the causes and variability in prognosis of amyotrophic lateral sclerosis and diabetic neuropathy.

3. Basic science studies to develop novel biomarkers for amyotrophic lateral sclerosis.

Representative Publications:
Gordon PH, Moore DH, Miller RG, Florence JM, Verheijde JL, Doorish C, Hilton JF, Spitalny GM, MacArthur RB, Mitsumoto H, Neville HE, Boylan K, Mozaffar T, Belsh JM, Ravits J, Bedlack RS, Graves MC, McCluskey LF, Barohn RJ, Tandan R, . Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial. Lancet Neurol. 2007 Dec;6(12):1045-53. (2007) Abstract

Bedlack RS, Traynor BJ, Cudkowicz ME. Emerging disease-modifying therapies for the treatment of motor neuron disease/amyotropic lateral sclerosis. Expert Opin Emerg Drugs. 2007 May;12(2):229-52. (2007) Abstract